You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 4, October 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Concentration of Gentamicin in Experimental Corneal Ulcers

Topical vs Subconjunctival Therapy

Jules L. Baum, MD; Michael Barza, MD; Donald Shushan; Louis Weinstein, MD, PhD

Arch Ophthalmol. 1974;92(4):315-317.


Abstract

Topical and subconjunctival therapy with gentamicin sulfate were compared in rabbits following the induction of Pseudomonas and lye corneal ulcers. The concentrations of antibiotic in the cornea were significantly higher with the subconjunctival than with the topical route for Pseudomonas ulcers. In the case of lye ulcers, however, the difference was not statistically significant. Therapeutic levels of gentamicin were maintained in corneal ulcers for at least six hours after a subconjunctivally given injection. In contrast, less than 1µg of the agent was detectable per gram of cornea one hour after cessation of topical application. This study suggests that bacterial ulcers of the cornea might best be managed with a combination of subconjunctival and frequent topical treatment.



Author Affiliations

From the departments of ophthalmology (Dr. Baum) and medicine—infectious disease section (Drs. Barza and Weinstein), New England Medical Center Hospital and Tufts University School of Medicine, Boston.


Footnotes

Submitted for publication April 27, 1973.

Reprint requests to Department of Ophthalmology, New England Medical Center Hospital, 171 Harrison Ave, Boston, MA 02111 (Dr. Baum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu et al.
IOVS 2008;49:333-341.
ABSTRACT | FULL TEXT  

Gentamicin, Tobramycin, Amikacin, and Netilmicin Levels in Tears Following Intravenous Administration
Woo et al.
Arch Ophthalmol 1985;103:216-218.
ABSTRACT  

Route of Antibiotic Administration in Bacterial Keratitis
Leibowitz et al.
Arch Ophthalmol 1981;99:1420-1423.
ABSTRACT  

Topical Antibiotic Therapy of Pseudomonas aeruginosa Keratitis
Kupferman and Leibowitz
Arch Ophthalmol 1979;97:1699-1702.
ABSTRACT  

Periocular Injection of Corticosteroids: An Experimental Evaluation of Its Role in the Treatment of Corneal Inflammation
Leibowitz and Kupferman
Arch Ophthalmol 1977;95:311-314.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.